Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | HMGCL |
| Upstream (Parents) |
|---|
| (<<) HRSP12 → HMGCL |
| (<<) ETFDH → HMGCL |
| Downstream (Children) |
|---|
| HMGCL → ALDH6A1 (>>) |
| HMGCL → NPTXR (>>) |
| HMGCL → DDO (>>) |
| HMGCL → HAS2 (>>) |
| HMGCL → ETFDH (>>) |
| HMGCL → GSTZ1 (>>) |
| HMGCL → SLC1A2 (>>) |
| HMGCL → BDH1 (>>) |
| HMGCL → CLDN14 (>>) |
| HMGCL → PEMT (>>) |
| HMGCL → PIP (>>) |
| HMGCL → INSIG1 (>>) |
| HMGCL → PCK2 (>>) |
| HMGCL → ADI1 (>>) |
| HMGCL → HAGH (>>) |
| HMGCL → STBD1 (>>) |
| HMGCL → AK3L2///AK4 (>>) |
| HMGCL → PQLC1 (>>) |
| HMGCL → ABCA5 (>>) |
| HMGCL → SCCPDH (>>) |
| HMGCL → MTHFS (>>) |
| HMGCL → SRD5A1 (>>) |
| HMGCL → MEGF9 (>>) |
| HMGCL → ECH1 (>>) |
